1Applegarth D, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics, 2000, 105 :e10. 被引量：1
2Wilcken B, Wiley V, Hammond J, et al. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med, 2003, 348:2304 -2312. 被引量：1
3Rashed MS. Clinical applications of tandem mass spectrometry: ten years of diagnosis and screening for inherited metabolic diseases. J Chromat B, 2001, 758: 27-48. 被引量：1
4Pandor A, Eaatham J, Beverley C, et al. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review. Health Technol Assess, 2004, 8:1-121. 被引量：1
5Feuchtbaum L, Cunningham G. Economic evaluation of tandem mass spectrometry screening in California. Pediatrics, 2006, 117:280-286. 被引量：1
6Grosse SD, Khoury MJ, Greene CL, et al. The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update. Genet Med, 2006, 8:205-212. 被引量：1
7Futerman AH, Sussman JL, Horowitz M, et al. New directions in the treatment of Gaucher disease. Trends Pharm Sci, 2004, 25:147-151. 被引量：1
8Wang L, Gamez A, Sarkissian CN, et al. Structure-based chemical modification strategy for enzyme replacement treatment of phenylketonuria. Mol C, enet Metab, 2005, 86:134-140. 被引量：1
